Cryptosporidium immune globulin - GalaGen

Drug Profile

Cryptosporidium immune globulin - GalaGen

Alternative Names: Sporidin-G

Latest Information Update: 23 Dec 1999

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator GalaGen
  • Class Antibodies; Antiparasitics
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cryptosporidiosis

Most Recent Events

  • 23 Dec 1999 Discontinued-III for Cryptosporidiosis in USA (PO)
  • 09 Oct 1997 Suspended-III for Cryptosporidiosis in USA (PO)
  • 24 Jun 1997 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top